Swiss All Share Index

Swiss All Share Index handeln
19.925,85 PKT +61,11 PKT +0,31 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

ISIN CH0009111011


Analysen zu Swiss All Share Index-Werten

Datum Rating Analyst
07.12.12 Clariant hold Deutsche Bank AG
07.12.12 Givaudan sell Deutsche Bank AG
07.12.12 BELIMO hold Vontobel Research
06.12.12 Nestlé hold Deutsche Bank AG
05.12.12 UBS buy Deutsche Bank AG
05.12.12 Richemont hold Vontobel Research
04.12.12 Swiss Re buy Société Générale Group S.A. (SG)
04.12.12 Swiss Prime Site hold Vontobel Research
04.12.12 Sonova overweight Morgan Stanley
04.12.12 Richemont hold Renaissance Capital
04.12.12 Julius Bär reduce Vontobel Research
03.12.12 ARYZTA hold Vontobel Research
03.12.12 Nestlé hold Vontobel Research
03.12.12 Kühne + Nagel International hold Vontobel Research
03.12.12 Galenica reduce Vontobel Research
03.12.12 Zurich Insurance buy Nomura
03.12.12 ARYZTA neutral Sarasin Research
03.12.12 Nestlé overweight Morgan Stanley
03.12.12 Swatch (I) buy Goldman Sachs Group Inc.
03.12.12 Clariant underperform Credit Suisse Group
30.11.12 ABB (Asea Brown Boveri) neutral HSBC
30.11.12 Zurich Insurance neutral J.P. Morgan Cazenove
30.11.12 UBS outperform Exane-BNP Paribas SA
30.11.12 ARYZTA hold Société Générale Group S.A. (SG)
30.11.12 Holcim hold Société Générale Group S.A. (SG)
30.11.12 Holcim overweight Morgan Stanley
30.11.12 Holcim equal-weight Morgan Stanley
30.11.12 Novartis outperform Sanford C. Bernstein and Co., Inc.
30.11.12 Zurich Insurance hold Vontobel Research
30.11.12 Zurich Insurance outperform Sanford C. Bernstein and Co., Inc.
29.11.12 Swiss Life neutral J.P. Morgan Cazenove
29.11.12 Zurich Insurance neutral Sarasin Research
29.11.12 Swiss Life buy Nomura
29.11.12 Richemont buy Sarasin Research
29.11.12 Swiss Life buy Vontobel Research
29.11.12 Lonza hold Vontobel Research
29.11.12 Zurich Insurance hold Vontobel Research
28.11.12 UBS outperform Credit Suisse Group
28.11.12 Swiss Re neutral Exane-BNP Paribas SA
28.11.12 UBS overweight J.P. Morgan Cazenove